Biocryst Pharmaceuticals (BCRX) Other Working Capital Changes (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) posted Other Working Capital Changes of -$749000.0 for Q1 2026, down 78.76% on a QoQ basis from -$419000.0 in Q4 2023.
Biocryst Pharmaceuticals (BCRX) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Biocryst Pharmaceuticals' Other Working Capital Changes history runs 7 years deep, the most recent figure standing at -$749000.0 for Q1 2026.
- Quarterly Other Working Capital Changes changed N/A year-over-year to -$749000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$749000.0 (changed N/A YoY) and the FY2023 annual result came in at -$1.2 million, down 1028.44% from the prior year.
- Other Working Capital Changes was -$749000.0 for Q1 2026 at Biocryst Pharmaceuticals, down from -$419000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $6.0 million in Q3 2023 and bottomed at -$3.5 million in Q1 2026.
- A 5-year average of $690529.4 and a median of $82000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Peak annual rise in Other Working Capital Changes reached 413.51% in 2023, while the deepest fall reached 1041.26% in 2023.
- Biocryst Pharmaceuticals' Other Working Capital Changes stood at -$438000.0 in 2022, then increased by 4.34% to -$419000.0 in 2023, then sank by 78.76% to -$749000.0 in 2026.
- Business Quant data shows BCRX's Other Working Capital Changes at -$749000.0 in Q1 2026, -$419000.0 in Q4 2023, and -$1.3 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Biocryst Pharmaceuticals | 2.27 Bn | 2.20 Bn | 151.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.53 Mn |
| Mar 31, 2026 | -3.53 Mn |
| Mar 31, 2026 | -3.53 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Dec 31, 2025 | 1.94 Mn |
| Sep 30, 2025 | 5.92 Mn |
| Sep 30, 2025 | 5.92 Mn |
| Sep 30, 2025 | 5.92 Mn |
| Jun 30, 2025 | -160,000.00 |
| Jun 30, 2025 | -160,000.00 |
| Jun 30, 2025 | -160,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Mar 31, 2025 | 132,000.00 |
| Dec 31, 2024 | -574,000.00 |
| Dec 31, 2024 | -574,000.00 |
| Dec 31, 2024 | -574,000.00 |
| Sep 30, 2024 | 1.47 Mn |
| Sep 30, 2024 | 1.47 Mn |